Why healthcare providers should focus on the fertility of AYA cancer survivors: It's not too late!

Frontiers in Oncology

Volumn 3 OCT, Issue , 2013, Pages

  Murphy, Devin ^a   Orgel, Etan ^a,b   Termuhlen, Amanda ^a,b   Shannon, Susan ^a   Warren, Krista ^a   Quinn, Gwendolyn P ^c,d  

^a MILLER CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adolescent and young adult; Discussion; Fertility; Oncology; Survivorship

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; ESTROGEN; FIBRINOGEN; FOLLITROPIN; GONADORELIN; OSTEOCALCIN; PROCARBAZINE; PROLACTIN; TESTOSTERONE;

ADOLESCENT; ARTICLE; BONE; BONE DENSITY; BONE MASS; CANCER SURVIVOR; CANCER THERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CHRONIC DISEASE; COMORBIDITY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FERTILITY; HEALTH CARE PERSONNEL; HUMAN; HYPERPROLACTINEMIA; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; NEOPLASM; OSSIFICATION; PHYSIOLOGY; PREMATURE OVARIAN FAILURE; QUALITY OF LIFE; REPRODUCTIVE HEALTH; SEXUALLY TRANSMITTED DISEASE; TESTICULAR SPERM EXTRACTION; YOUNG ADULT;

EID: 84891099358     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00248     Document Type: Article

References (84)

1. Zebrack BJ, Casillas J, Nohr L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology (2004) 13:689-99. doi:10.1002/pon.784
2. Waimey KE, Duncan FE, Su HI, Smith K, Wallach H, Jona K, et al. Future directions in oncofertility and fertility preservation: a report from the 2011 oncofertility consortium conference. J Adolesc Young Adult Oncol (2013) 2:25-30. doi:10.1089/jayao.2012.0035
3. Murphy D, Klosky JL, Termuhlen A, Sawczyn KK, Quinn GP. The need for reproductive and sexual health discussions with adolescent and young adult cancer patients. Contraception (2012) 88(2):215-20. doi:10.1016/j.contraception.2012.08.041
4. Klosky JL, Gamble HL, Spunt SL, Randolph ME, Green DM, Hudson MM. Human papillomavirus vaccination in survivors of childhood cancer. Cancer (2009) 115:5627-36. doi:10.1002/cncr.24669
5. Bahadur G. Fertility issues for cancer patients. Mol Cell Endocrinol (2000) 169:117-22. doi:10.1016/S0303-7207(00)00364-6
6. Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR, et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant (2012) 47:271-6. doi:10.1038/bmt.2011.78
7. Grigg AP, McLachlan R, Zaja J, Szer J. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120/mg/kg). Bone Marrow Transplant (2000) 26:1089-95. doi:10.1038/sj.bmt.1702695
8. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod (2008) 23:2266-72. doi:10.1093/humrep/den244
9. Goodwin T, Oosterhuis BE, Kiernan M, Hudson MM, Dahl GV. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr Blood Cancer (2007) 48:80-5. doi:10.1002/pbc.20814
10. Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists' views. J Cancer Surviv (2007) 1:146-55. doi:10.1007/s11764-007-0019-9
11. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol (2002) 20:1890-7. doi:10.1200/JCO.2002.07.174
12. Madan-Swain A, Brown RT, Foster MA, Vega R, Byars K, Rodenberger W, et al. Identity in adolescent survivors of childhood cancer. J Pediatr Psychol (2000) 25:105-15. doi:10.1093/jpepsy/25.2.105
13. Horwitz AV, White HR. The relationship of cohabitation and mental health: a study of a young adult cohort. J Marriage Fam (1998) 60:505-14. doi:10.1007/s10519-011-9509-7
14. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group late effects committee and nursing discipline. J Clin Oncol (2004) 22:4979-90. doi:10.1200/JCO.2004.11.032
15. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, et al. Acute ovarian failure in the childhood cancer survivor study. JCEM (2006) 91:1723-8.
16. Kenney LB, Cohen LE, Shnorhavorian M, Metzger ML, Lockart B, Hijiya N, et al. Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol (2012) 30:3408-16. doi:10.1200/JCO.2011.38.6938
17. Metzger ML, Meacham LR, Patterson B, Casillas JS, Constine LS, Hijiya N, et al. Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol (2013) 31:1239-47. doi:10.1200/JCO.2012.43.5511
18. Fallat ME, Hutter J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics (2008) 121:e1461-9. doi:10.1542/peds.2008-0593
19. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol (2006) 24:2917-31. doi:10.1200/JCO.2006.06.5888
20. Klosky JL, Howell CR, Li Z, Foster RH, Mertens AC, Robison LL, et al. Risky health behavior among adolescents in the childhood cancer survivor study cohort. J Pediatr Psychol (2012) 37:634-46. doi:10.1093/jpepsy/jss046
21. Surís JC, Resnick MD, Cassuto N, Blum RW. Sexual behavior of adolescents with chronic disease and disability. J Adolesc Health (1996) 19:124-31. doi:10.1016/1054-139X(95)00282-W
22. Prasad PK, Signorello LB, Friedman DL, Boice JD, Pukkala E. Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer (2012) 58:421-7. doi:10.1002/pbc.23296
23. Busia A, Laffranchi A, Viviani S, Bonfante V, Villani F. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease. Anticancer Res (2010) 30:4381-7.
24. Fulbright JM. Review of cardiotoxicity in pediatric cancer patients: during and after therapy. Cardiol Res Pract (2011) 2011:9420-90. doi:10.4061/2011/942090
25. Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol (1997) 15:1544-52.
26. Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Long-term overall and cardiovascular mortality following childhood cancer: the role of cancer treatment. J Clin Oncol (2010) 28:1308-15. doi:10.1200/JCO.2008.20.2267
27. Bovelli D, Plataniotis G, Roila F. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines. Ann Oncol (2010) 21(Suppl 5):v277-82. doi:10.1093/annonc/mdq200
28. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart (2008) 94:525-33. doi:10.1136/hrt.2007.136093
29. Yorgun H, Tokgözoglu L, Canpolat U, Gürses KM, Bozdag G, Yapici Z, et al. The cardiovascular effects of premature ovarian failure. Int J Cardiol (2013) 168(1):506-10. doi:10.1016/j.ijcard.2012.09.197
30. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 316:1105. doi:10.1056/NEJM198704303161801
31. Cignarella A, Kratz M, Bolego C. Emerging role of estrogen in the control of cardiometabolic disease. Trends Pharmacol Sci (2010) 31:183-9. doi:10.1016/j.tips.2010.01.001
32. Nadkarni S, Cooper D, Brancaleone V, Bena S, Perretti M. Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes. Arterioscler Thromb Vasc Biol (2011) 31:2749-59. doi:10.1161/ATVBAHA.111.235176
33. Tirabassi G, Gioia A, Giovannini L, Boscaro M, Corona G, Carpi A, et al. Testosterone and cardiovascular risk. Intern Emerg Med (2013) 8(Suppl 1):S65-9. doi:10.1007/s11739-013-0914-1
34. Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation (1999) 100:1690-6. doi:10.1161/01.CIR.100.16.1690
35. Landy DC, Miller TL, Lopez-Mitnik GV, Lipsitz SR, Hinkle AS, Constine LS. Risk of atherosclerotic disease coronary artery lesions in childhood cancer survivors. J Clin Oncol (2010) 28(Suppl):e19586.
36. Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, et al. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res (1999) 14:2002-9. doi:10.1359/jbmr.1999.14.12.2002
37. Kaste SC, Chesney RW, Hudson MM, Lustig RH, Rose SR, Carbone LD. Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health. J Bone Miner Res (1999) 14:2010-4. doi:10.1359/jbmr.1999.14.12.2010
38. Köther M, Schindler J, Oette K, Berthold F. Abnormalities in serum osteocalcin values in children receiving chemotherapy including ifosfamide. In vivo (1992) 6:219-21.
39. Walsh JS, Henry YM, Fatayerji D, Eastell R. Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study. Osteoporos Int (2009) 20:355-62. doi:10.1007/s00198-008-0672-5
40. de Ronde W, Pols HA, van Leeuwen JP, de Jong FH. The importance of oestrogens in males. Clin Endocrinol (2003) 58:529-42. doi:10.1046/j.1365-2265.2003.01669.x
41. Aisenberg J, Hsieh K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol (1998) 20:241-5. doi:10.1097/00043426-199805000-00010
42. Asli IN, Fallahian M, Seddigh HR, Javadi H, Baharfar N, Assadi M. Evaluation of bone mineral density in premature ovarian failure. Hell J Nucl Med (2010) 13:261-3.
43. Uygur D, Sengül ö, Bayar D, Erdinç S, Batioglu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet (2005) 273:17-9. doi:10.1007/s00404-005-0029-7
44. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol (2001) 19:3306-11.
45. Pal L, Norian J, Zeitlian G, Bevilacqua K, Freeman R, Santoro N. Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 90:1626-34. doi:10.1016/j.fertnstert.2007.08.020
46. Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, et al. Bone metabolism and gonad function in male patients undergoing liver transplantation: a two year longitudinal study. Osteoporos Int (2001) 12:749-54. doi:10.1007/s001980170051
47. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, et al. Endocrine regulation of male fertility by the skeleton. Cell (2011) 144:796-809. doi:10.1016/j.cell.2011.02.004
48. Patterson BC, Wasilewski-Masker K, Ryerson AB, Mertens A, Meacham L. Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program. J Clin Endocrinol Metab (2012) 97:810-8. doi:10.1210/jc.2011-2104
49. Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, et al. Endocrine outcomes for children with embryonal brain tumors after risk adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem cell rescue on the SJMB-96 trial. J Clin Oncol (2008) 26:1112-8. doi:10.1200/JCO.2008.13.5293
50. Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96trial. J Clin Oncol (2008) 26:1112-8. doi:10.1200/JCO.2008.13.5293
51. Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev (1998) 19:144-72. doi:10.1210/er.19.2.144
52. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA (1988) 259:2123-5. doi:10.1001/jama.1988.03720140043031
53. Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F, et al. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol (2013) 168:465-72. doi:10.1530/EJE-12-1043
54. Andreu JAL, Fernandez PJ, Tortajada JFI, Navarro I, Rodriguez-Ineba A, Muro MD, et al. Persistent altered spermatogenesis in long-term childhood cancer survivors. Pediatr Hematol Oncol (2000) 17:21-30. doi:10.1080/088800100276631
55. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2001) 49:1079-92. doi:10.1016/S0360-3016(00)01387-0
56. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest (1998) 101:2622-9. doi:10.1172/JCI2081
57. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod (1993) 8:2080-7.
58. Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure under estimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer (2012) 118:1933-9. doi:10.1002/cncr.26403
59. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J. Serum anti-mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod (2003) 18:328-32. doi:10.1093/humrep/deg043
60. Matsumoto AM. Andropause clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci (2002) 57:M76-99. doi:10.1093/gerona/57.2.M76
61. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism (2000) 49:1239-42. doi:10.1053/meta.2000.8625
62. Quinn GP, Knapp C, Murphy D, Sawczyn K, Sender L. Congruence of reproductive concerns among adolescents with cancer and parents: pilot testing an adapted instrument. Pediatrics (2012) 129:e930-6. doi:10.1542/peds.2011-2568
63. Crawshaw M, Sloper P. A Qualitative Study of the Experiences of Teenagers and Young Adults when Faced with Possible or Actual Fertility Impairment following Cancer Treatment. University of York: York (2006).
64. Oppenheim D, Brugieres L, Hartmann O. Adolescents treated for cancer and fertility preservation. Psychological aspects. Gynecol Obstet Fertil (2005) 33:627-31. doi:10.1016/j.gyobfe.2005.07.005
65. Halliday LE, Boughton MA, Kerridge I. Mothering and self-othering: the impact of uncertain reproductive capability in young women after haematological malignancy. Health Care Women Int (2013). [Epub ahead of print] doi:10.1080/07399332.2013.770005
66. Staszak J. Other/Otherness. International Encyclopedia of Human Geography. London: Elsevier (2008).
67. Calvo JA, Moroski-Erkul CA, Lake A, Eichinger LW, Shah D, Jhun I, et al. Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1. PLoS Genet (2013) 9:e1003413. doi:10.1371/journal.pgen.1003413
68. Gradishar WJ, Schilsky RL. Ovarian function following radiation and chemotherapy for cancer. Semin Oncol (1989) 16:425-36.
69. Lendon M, Hann IM, Palmer MK, Shalet SM, Morris Jones PH. Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Lancet (1978) 312:439-41. doi:10.1016/S0140-6736(78)91442-3
70. Chan PT, Palermo GD, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer (2001) 92:1632-7. doi:10.1002/1097-0142(20010915)92:6<1632::AID-CNCR1489>3.0.CO;2-I
71. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet (2004) 364:1405-10. doi:10.1016/S0140-6736(04)17542-9
72. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med (2005) 353:318-21. doi:10.1056/NEJMc055237
73. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist (2007) 12:1437-42. doi:10.1634/theoncologist.12-12-1437
74. Anderson RA, Weddell A, Spoudeas HA, Douglas C, Shalet SM, Levitt G, et al. Do doctors discuss fertility issues before they treat young patients with cancer? Hum Reprod (2008) 23:2246-51. doi:10.1093/humrep/den252
75. Gosiengfiao YC, Reynolds M, Rajaram V, Lockart B, Smith K, Xu M, et al. Ovarian tissue cryopreservation in a prepubertal girl after fertility impairing therapy. J Clin Oncol (2001) 30:2012.
76. Howell SJ, Shalet SM. Damage to fertility by cancer and its treatments: spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr (2005) 2005:12-7. doi:10.1093/jncimonographs/lgi003
77. Naysmith TE, Blake DA, Harvey VJ, Johnson NP. Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod (1998) 13:3250-5. doi:10.1093/humrep/13.11.3250
78. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med (2000) 342:1919. doi:10.1056/NEJM200006223422516
79. Sibler SJ. Ovarian cryopreservation and transplantation for fertility preservation. Mol Hum Reprod (2012) 18:59-67. doi:10.1093/molehr/gar082
80. Lee S, Ku SY. Sex steroid production from cryopreserved and reimplanted ovarian tissue. In: Ostojic S, editor. Steroids-from Physiology to Clinical Medicine. InTech (2012). Available from: http://www.intechopen.com/books/steroids-from-physiology-to-clinical-medicine/
81. Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA (2001) 286:1490-3. doi:10.1001/jama.286.12.1490
82. Kim SS. Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J Assist Reprod Genet (2012) 29:489-93. doi:10.1007/s10815-012-9757-3
83. Wallace WH, Kelsey TW, Anderson RA. Ovarian cryopreservation: experimental or established and a cure for the menopause? Reprod Biomed Online (2012) 25:93-5. doi:10.1016/j.rbmo.2012.06.008
84. Keros V, Rosenlund B, Hultenby K, Aghajanova L, Levkov L, Hovatta O. Optimizing cryopreservation of human testicular tissue: comparison of protocols with glycerol, propanediol and dimethylsulphoxide as cryoprotectants. Hum Reprod (2005) 20:1676-87. doi:10.1093/humrep/deh797